CLINICAL_TRIALS
research
· 2013-09-16
Clinical Trial Update: A Clinical Pharmacology Study of JNS010 (Paliperidone Palmitate) in Patients With Schizophrenia [Phase 1]
Summary
A Phase 1 pharmacology study of JNS010 (paliperidone palmitate) in patients with schizophrenia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Pharmaceutical K.K. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED